This article explores how GLP-1 medications affect metabolism, who may benefit from treatment, and important safety considerations for UK patients
Akkermansia Muciniphila : Promising results for insulin sensitivity Akkermansia Muciniphila As for Akkermansia Muciniphila , a bacterium claimed by trending supplement brand Pendulum to increase GLP-1 production, he says, Its a pretty promising microbe when it comes to insulin sensitivity, but Ive not seen any human clinical data about Akkermansia, GLP-1 production and weight loss. On its website, the company (which includes actress Halle Berry among its investors) links to animal research showing that Akkermansia Muciniphila increased GLP-1 production in mice on a high-fat diet
Intranasal drug delivery devices and interventions associated with post-operative endoscopic sinus surgery
Genomics 46, 268275
Clinical Profile of Exenatide To understand subsequent innovations, its helpful to summarize exenatides clinical profile (as the first GLP-1 RA): Efficacy: In trials, twice-daily exenatide (10 g BID) typically reduced HbAc by approximately 0.8%1.0% more than placebo by 30 weeks ( [61] ) ( [101] )
